NeuroBo Pharmaceuticals (NASDAQ:NRBO) just reported results for the second quarter of 2024.
- NeuroBo Pharmaceuticals reported earnings per share of -$1.85. This was below the analyst estimate for EPS of -$1.12.
- The company did not report any revenue for the quarter.